FDA Inspection
Lifepharma FZELifepharma FZE – FDA Inspection, Nov 24, 2022
Record Details
This FDA Inspection record concerns Lifepharma FZE, with an inspection on November 24, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lifepharma FZE
- Inspection Date
- November 24, 2022
- Product Type
- Drugs
View Company Profile
ID · cac56b13-f6d6-4e19-9d79-f77379322949
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1191272
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lifepharma FZE
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2018 | Not classified | Office of Inspections and Investigations | |
| August 4, 2017 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
Other documents for Lifepharma FZE
- FDA Inspection 1070936 - 2018-09-27
- FDA Inspection 1020298 - 2017-08-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.